| Stock Investors Bid Up Shares of 3SBio, Up 4.1% - Financial News Network Online |
|
|
Financial News Network Online The Company researches treatments in the areas of nephrology, oncology, supportive cancer care, inflammation, and infectious diseases. 3SBio (NASDAQ:SSRX) has potential upside of 89.2% based on a current price of $9.99 and analysts' consensus price |